The activated TAA-specific CD4+ helper T cells and CTLs amass to the primary tumor site, where tumor-specific CTLs recognize and eliminate antigen-presenting tumor cells through secretion of perforin and induction of Fas/FasL-mediated apoptosis, while unknowingly selecting for less immunogenic tumor cells [8]. The gene discussed is FASLG; the disease is neoplasm.